Login / Signup
Tumour necrosis factor inhibitor monotherapy for CNS neurosarcoidosis.
Jeffrey Marc Gelfand
Published in:
Journal of neurology, neurosurgery, and psychiatry (2021)
Keyphrases
</>
combination therapy
blood brain barrier
open label
randomized controlled trial